Intracameral Recombinant Tissue Plasminogen Activator for Refractory Glaucoma Secondary to a Fungal Corneal Abscess

L. Jay Katz*, Oana Stirbu, Garth Willis, Parul Ichhpujani
Wills Eye Institute, 840 Walnut Street, Philadelphia, USA

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 1242
Abstract HTML Views: 1039
PDF Downloads: 322
Total Views/Downloads: 2603
Unique Statistics:

Full-Text HTML Views: 704
Abstract HTML Views: 658
PDF Downloads: 219
Total Views/Downloads: 1581

© Katzet al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Glaucoma service, Wills Eye Institute, 840 Walnut Street, Philadelphia, USA; Tel: 215-285-8148; Fax: 215- 928-3903; E-mail:


We present a 78-year-old patient who developed refractory glaucoma following a fungal infection of the corneal incision after cataract extraction with posterior chamber intraocular lens implantation. An anterior chamber injection of 0.1 ml recombinant tissue plasminogen activator (25 mcg/0.1 mL) was performed to improve the trabecular meshwork outflow facility compromised secondary to fibrin blockade. The intraocular pressure dropped dramatically from 48 mmHg to 10 mmHg postoperatively, negating the need for glaucoma surgery.